• 1011 Citations
  • 16 h-Index
1987 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 15 Similar Profiles
Hepatocellular Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Protein C Inhibitor Medicine & Life Sciences
Liver Neoplasms Medicine & Life Sciences
Protein Kinase Inhibitors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 1987 2019

  • 1011 Citations
  • 16 h-Index
  • 31 Article
  • 2 Review article
  • 1 Letter
Hepatocellular Carcinoma
Survival
Therapeutics
Confidence Intervals
Drug Therapy
1 Citation (Scopus)
Liver Neoplasms
Microspheres
Therapeutics
Transplantation
Yttrium
4 Citations (Scopus)
Colorectal Neoplasms
Radiotherapy
Drug Therapy
Survival
Neoplasms
End Stage Liver Disease
Hepatocellular Carcinoma
Sodium
Survival
Mortality
82 Citations (Scopus)

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

KEYNOTE-224 investigators, Jul 1 2018, In : The Lancet Oncology. 19, 7, p. 940-952 13 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
pembrolizumab
sorafenib
Therapeutics
Disease Progression